NCT06785441 Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
| NCT ID | NCT06785441 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Prostate Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 180 participants |
| Start Date | 2023-05-25 |
| Primary Completion | 2027-02-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 180 participants in total. It began in 2023-05-25 with a primary completion date of 2027-02-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This protocol describes pilot testing of an educational shared decision-making intervention to help men with localized prostate cancer make decisions with their health care providers about if and when to de-escalate surveillance testing. The project is important because for many patients their cancer does not progress to the point of needed curative treatment or their health status changes such that they are no longer good candidates for treatment. For these men, de-escalating ongoing surveillance (e.g., fewer biopsies or imaging studies) is a reasonable option.
Eligibility Criteria
Inclusion Criteria: Patients: 1. Males aged 65 or older 2. Diagnosis of localized prostate cancer 3. Have not received curative intent treatment for their prostate cancer 4. Fluent in English Care partners/caregivers: 1. Aged 18 or older 2. Fluent in English 3. Involved with the care of an eligible patient (i.e. partner, close friend, family member, companion) Exclusion Criteria: Patients 1\. Currently receiving treatment for another cancer (primary or recurrence) Care partners/caregivers 1\. None
Contact & Investigator
Lisa Lowenstein, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT06785441 clinical trial?
This trial is open to male participants only, aged 65 Years or older, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06785441 currently recruiting?
Yes, NCT06785441 is actively recruiting participants. Contact the research team at deescalatepca@mdanderson.org for enrollment information.
Where is the NCT06785441 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06785441 clinical trial?
NCT06785441 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Lisa Lowenstein, MD at M.D. Anderson Cancer Center. The trial plans to enroll 180 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.